Abstract B135: Activity of Tegavivint in Hepatocellular Carcinoma with Aberrant Wnt/β-catenin Signaling and Evaluation of Biomarker ResponseCiara Curran, Thomas G. Bird, Aundrietta D. Duncan et al.|Molecular Cancer Therapeutics|2025Cited by 0